Suppr超能文献

用于作为药物制剂的细胞内化核酸适配体的摄取机制。

Uptake mechanisms of cell-internalizing nucleic acid aptamers for applications as pharmacological agents.

作者信息

Alamudi Samira Husen, Kimoto Michiko, Hirao Ichiro

机构信息

Institute of Bioengineering and Bioimaging (IBB), Agency for Science, Technology and Research (ASTAR) 31 Biopolis Way, Nanos #07-01 Singapore 138669 Singapore

出版信息

RSC Med Chem. 2021 Jul 24;12(10):1640-1649. doi: 10.1039/d1md00199j. eCollection 2021 Oct 20.

Abstract

Nucleic acid aptamers, also regarded as chemical antibodies, show potential as targeted therapeutic and delivery agents since they possess unique advantages over antibodies. Generated by an iterative selection and amplification process from oligonucleotide libraries using cultured cells, the aptamers bind to their target molecules expressed on the cell surface. Excitingly, most aptamers also demonstrate a cell-internalizing property in native living cells, allowing them to directly enter the cells endocytosis depending on the target. In this review, we discuss selection methods in generating cell-internalizing aptamers a cell-based selection process, along with their challenges and optimization strategies. We highlight the cellular uptake routes adopted by the aptamers and also their intracellular fate after the uptake, to give an overview of their mechanism of action for applications as promising pharmacological agents.

摘要

核酸适配体,也被视为化学抗体,因其相对于抗体具有独特优势,故而展现出作为靶向治疗和递送剂的潜力。通过使用培养细胞从寡核苷酸文库中进行迭代筛选和扩增过程产生的适配体,会与细胞表面表达的靶分子结合。令人兴奋的是,大多数适配体在天然活细胞中也表现出细胞内化特性,这使它们能够根据靶标通过内吞作用直接进入细胞。在本综述中,我们讨论了生成细胞内化适配体的筛选方法——一种基于细胞的筛选过程,以及它们面临的挑战和优化策略。我们着重介绍了适配体所采用的细胞摄取途径以及摄取后它们在细胞内的命运,以概述其作为有前景的药物制剂的作用机制。

相似文献

1
Uptake mechanisms of cell-internalizing nucleic acid aptamers for applications as pharmacological agents.
RSC Med Chem. 2021 Jul 24;12(10):1640-1649. doi: 10.1039/d1md00199j. eCollection 2021 Oct 20.
2
Cell-targeting aptamers act as intracellular delivery vehicles.
Appl Microbiol Biotechnol. 2016 Aug;100(16):6955-69. doi: 10.1007/s00253-016-7686-2. Epub 2016 Jun 28.
3
Cell-SELEX Technology.
Biores Open Access. 2012 Dec;1(6):265-72. doi: 10.1089/biores.2012.0253.
5
Selection of Nucleic Acid Aptamers Targeting Tumor Cell-Surface Protein Biomarkers.
Cancers (Basel). 2017 Jun 21;9(6):69. doi: 10.3390/cancers9060069.
6
In vitro evolution of chemically-modified nucleic acid aptamers: Pros and cons, and comprehensive selection strategies.
RNA Biol. 2016 Dec;13(12):1232-1245. doi: 10.1080/15476286.2016.1236173. Epub 2016 Oct 7.
7
The therapeutic potential of cell-internalizing aptamers.
Curr Top Med Chem. 2009;9(12):1144-57. doi: 10.2174/156802609789630893.
8
Cell-specific internalization study of an aptamer from whole cell selection.
Chemistry. 2008;14(6):1769-75. doi: 10.1002/chem.200701330.
10
Aptamers for Targeted Drug Delivery.
Pharmaceuticals (Basel). 2010 May 27;3(6):1761-1778. doi: 10.3390/ph3061761.

引用本文的文献

2
Aptamer-ODN Chimeras: Enabling Cell-Specific ODN Targeting Therapy.
Cells. 2025 May 12;14(10):697. doi: 10.3390/cells14100697.
3
Design strategies for organelle-selective fluorescent probes: where to start?
RSC Adv. 2025 Jan 22;15(3):2115-2131. doi: 10.1039/d4ra08032g. eCollection 2025 Jan 16.
7
DNA-Based Nanomaterials as Drug Delivery Platforms for Increasing the Effect of Drugs in Tumors.
Cancers (Basel). 2023 Apr 5;15(7):2151. doi: 10.3390/cancers15072151.
9
Aptamer‑based therapy for targeting key mediators of cancer metastasis (Review).
Int J Oncol. 2022 Jun;60(6). doi: 10.3892/ijo.2022.5355. Epub 2022 Apr 15.

本文引用的文献

1
Recent progress in non-native nucleic acid modifications.
Chem Soc Rev. 2021 Apr 26;50(8):5126-5164. doi: 10.1039/d0cs01430c.
2
Functional Aptamer-Embedded Nanomaterials for Diagnostics and Therapeutics.
ACS Appl Mater Interfaces. 2021 Mar 3;13(8):9542-9560. doi: 10.1021/acsami.0c19562. Epub 2021 Feb 17.
3
Redesigning the Genetic Polymers of Life.
Acc Chem Res. 2021 Feb 16;54(4):1056-1065. doi: 10.1021/acs.accounts.0c00886. Epub 2021 Feb 3.
4
Base-modified aptamers obtained by cell-internalization SELEX facilitate cellular uptake of an antisense oligonucleotide.
Mol Ther Nucleic Acids. 2020 Nov 26;23:440-449. doi: 10.1016/j.omtn.2020.11.016. eCollection 2021 Mar 5.
6
Genetic alphabet expansion technology by creating unnatural base pairs.
Chem Soc Rev. 2020 Nov 7;49(21):7602-7626. doi: 10.1039/d0cs00457j. Epub 2020 Oct 5.
7
Cell-SELEX, an Effective Way to the Discovery of Biomarkers and Unexpected Molecular Events.
Adv Biosyst. 2019 Dec;3(12):e1900193. doi: 10.1002/adbi.201900193. Epub 2019 Nov 12.
8
Evolution of abiotic cubane chemistries in a nucleic acid aptamer allows selective recognition of a malaria biomarker.
Proc Natl Acad Sci U S A. 2020 Jul 21;117(29):16790-16798. doi: 10.1073/pnas.2003267117. Epub 2020 Jul 6.
9
Advances of aptamers screened by Cell-SELEX in selection procedure, cancer diagnostics and therapeutics.
Anal Biochem. 2020 Jun 1;598:113620. doi: 10.1016/j.ab.2020.113620. Epub 2020 Feb 19.
10
Selection of Aptamers with Large Hydrophobic 2'-Substituents.
J Am Chem Soc. 2020 Feb 5;142(5):2125-2128. doi: 10.1021/jacs.9b10538. Epub 2020 Jan 21.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验